comparemela.com

Latest Breaking News On - Marek jasinski - Page 1 : comparemela.com

BMGB Capital Corp.: Navco Pharmaceuticals Inc. Announces Closing of Qualifying Transaction

Vancouver, British Columbia (Newsfile Corp. - April 13, 2023) - Navco Pharmaceuticals Inc. (TSXV: NAV) ("Navco" or the "Company", formerly known as BMGB Capital Corp.) is pleased to announce that it

Navco Pharmaceuticals Inc. Announces Closing of Qualifying Transaction

Navco Pharmaceuticals Inc. Announces Closing of Qualifying Transaction
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

BioStable Science & Engineering, Inc.: BioStable Science & Engineering Initiates European Commercialization of the HAART 200 Aortic Annuloplasty Device

BioStable Science & Engineering, Inc.: BioStable Science & Engineering Initiates European Commercialization of the HAART 200 Aortic Annuloplasty Device
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Sweet Earth Holdings Corp.: Sweet Earth Commences Key CBD Bioavailability Research

Sweet Earth Holdings Corp.: Sweet Earth Commences Key CBD Bioavailability Research CSE: SE) Sweet Earth the Company ) is pleased to announce it has commenced bioavailability research on CBD isolate and CBD broad spectrum particle size with NAVCO Pharmaceuticals Limited ( Navco ), an accredited laboratory located in Burlington, Ontario. The Company understands that the bioavailability of CBD skin and muscle products is significantly impacted by skin permeation processes associated with nano-particle delivery systems. As an industry leader in developing high-end CBD products for discerning customers, Sweet Earth is also committed to leading scientific research in the efficacy of CBD products as well.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.